Formal Convergent Synthesis
of Ivermectin Aglycone - A Synthetic Approach to the C10-C25
Subunit of Avermectins 2b

Vivien Henryon; Jean-Pierre Férézou

doi:10.1055/s-0029-1216954

PAPER

Formal Convergent Synthesis of Ivermectin Aglycone - A Synthetic Approach to the C10-C25 Subunit of Avermectins 2b

Vivien Henryon^a, Jean-Pierre Férézou*^b
^a Activation Chemical Process Research & Catalysis, 11, avenue Albert Einstein, 69100 Villeurbanne, France
Fax: +33(4)78931964;
^b Laboratoire de Syntèse Organique, DCSO, UMR CNRS 7652, Ecole Polytechnique, 91128 Palaiseau cedex, France
Fax: +33(1)69335972; e-Mail: ferezou@dcso.polytechnique.fr;

Abstract

All articles of this category

Abstract

A convergent, two-fragment synthesis of the C10-C25 northern moiety of avermectins has been developed. Along with our previous work in this area, the present contribution represents a formal synthesis of Ivermectin aglycone. Furthermore, according to a strategy leading to non γ-pyranone adducts from the condensation reaction between acetylacetone dianion and convenient aldehydes, 23-hydroxylated C10-C25 northern building blocks required for the synthesis of the avermectins series 2b were prepared. Subsequent unexpected kinetically favored unnatural (21S)-spiro isomers were obtained under mild cyclization conditions.

Key words

antibiotics - stereoselective synthesis - macrocycles - spiro compounds - cyclizations

Full Text

References

For reviews, see:

1a Fisher MH. The Avermectins, In Recent Advances in the Chemistry of Insect Control Janes NF. The Royal Society of Chemistry, Special Edition; London: 1985. p.53

1b Davies HG. Green RH. Nat. Prod. Rep. 1986, 3: 87

1c Crimmins MT. Hollis WG. O’Mahony R. In Studies in Natural Products Chemistry: Stereoselective Synthesis Vol. 1: Atta-Ur-Rahman . Elsevier; Amsterdam: 1988. Part A. p.435

1d Blizzard T. Fisher MH. Mrozik H. Shih TL. In Recent Progress in the Chemical Synthesis of Antibiotics Lukacs G. Ohno M. Springer-Verlag; New York: 1990. p.65

1e Davies GR. Green H. Chem. Soc. Rev. 1991, 20: 211

1f Davies GR. Green H. Chem. Soc. Rev. 1991, 20: 271

1g Blizzard TA. Org. Prep. Proceed. Int. 1994, 26: 617

2 Omura S. Int. J. Antimicrob. Agents 2008, 31: 91 ; and references therein

3 Rouge dos Santos A. Falcão CAB. Muzitano MF. Kaiser CR. Rossi-Bergmann B. Férézou J.-P. Bioorg. Med. Chem. 2009, 17: 496

For reports on avermectin B1a, see:

4a Hanessian S. Ugolini A. Dubé D. Hodges PJ. André C. J. Am. Chem. Soc. 1986, 108: 2776

4b Hanessian S. Ugolini A. Hodges PJ. Beaulieu P. Dubé D. André C. Pure Appl. Chem. 1987, 59: 299

4c Armstrong A. Ley SV. Synlett 1990, 323

4d Diez-Martin D. Grice P. Kolb HC. Ley SV. Madin A. Synlett 1990, 326

4e Armstrong A. Ley SV. Madin A. Mukherjee S. Synlett 1990, 328

4f Ley SV. Armstrong A. Diez-Martin D. Ford MJ. Grice P. Knight JG. Kolb HC. Madin A. Marby CA. Mukherjee S. Shaw AN. Slawin AMZ. Vile S. White AD. Williams DJ. Woods M. J. Chem. Soc., Perkin Trans. 1 1991, 667

4g White JD. Bolton GL. J. Am. Chem. Soc. 1990, 112: 1626

4h For reports on avermectin A1a, see: White JD. Bolton GL. Dantanarayana AP. Fox CMJ. Hiner RN. Jackson RW. Sakuma K. Warrier US. J. Am. Chem. Soc. 1995, 117: 1908

4i Danishefsky SJ. Armistead DM. Wincott FE. Selnick HG. Hungate R. J. Am. Chem. Soc. 1987, 109: 8117

4j Danishefsky SJ. Armistead DM. Wincott FE. Selnick HG. Hungate R. J. Am. Chem. Soc. 1989, 111: 2967

5 Férézou J.-P. Julia M. Li Y. Liu LW. Pancrazi A. Bull. Soc. Chim. Fr. 1995, 132: 428 ; and references therein

6 As a recent example, see: Kolar L. Erzen N. Logerwerf . Van Gestel CAM. Environ. Pollut. 2008, 151: 182

7 Kaplan RM. Trends Parasitol. 2004, 20: 477

8a Prichard R. Veterinary Parasitol. 2005, 133: 243

8b Prichard R. Expert Opin. Drug Discovery 2007, 2: S41

9 Pitterna T. Cassayre J. Hüter OF. Jung PMJ. Maienfisch P. Murphy Kessabi F. Quaranta L. Tobler H. Bioorg. Med. Chem. 2009, 17: 4085

10 Didier A. Loor F. Anticancer Drugs 1996, 745

11a Korystov Y. Ermakova N. Kublik L. Levitman M. Shaposhnikova V. Mosin V. Drinyaev V. Kruglyak E. Novik T. Sterlina T. Eur. J. Pharmacol. 2004, 493: 57

11b Drinyaev VA. Mosin VA. Kruglyak EB. Novik TS. Sterlina TS. Ermakova NV. Kublik LN. Levitman MKh. Shaposhnikova VV. Korystov YN. Eur. J. Pharmacol. 2004, 501: 19

12 Menager E. Merifield E. Smallridge M. Thomas EJ. Tetrahedron 1997, 53: 9377

13 Férézou J.-P. Gauchet-Prunet J. Julia M. Pancrazi A. Tetrahedron Lett. 1988, 30: 3667

14 Férézou J.-P. Julia M. Li Y. Liu L.-W. Pancrazi A. Porteu F. Bull. Soc. Chim. Fr. 1994, 131: 865

15 Henryon V. Liu LW. Lopez R. Prunet J. Férézou J.-P. Synthesis 2001, 16: 2401

16a Danishefsky SJ. Harvey DF. Quallich G. Uang BJ. J. Org. Chem. 1984, 49: 393

16b Danishefsky SJ. Pearson WH. Harvey DF. Maring CJ. Springer JP. J. Am. Chem. Soc. ,

16c Peterson JR. Kirchhoff EW. Synlett 1990, 394

17a Baker R. Swain CJ. Head JC. J. Chem. Soc., Chem. Commun. 1985, 309

17b Baker R. Swain CJ. Head JC. J. Chem. Soc., Perkin Trans. 1 1988, 85

18 Viala J. Munier P. Santelli M. Tetrahedron 1991, 47: 3347

19a Isobe M. Kitamura M. Goto T. J. Am. Chem. Soc. 1982, 104: 4997

19b Kitamura M. Isobe M. Ichikawa Y. Goto T. J. Am. Chem. Soc. 1984, 106: 3252

20 For a review, see: Hoppe D. Hense T. Angew. Chem., Int. Ed. Engl. 1997, 36: 2282

21 Dale JA. Dull DL. Mosher HS. J. Org. Chem. 1969, 34: 2543

22 Cooper GK. Dolby LJ. Tetrahedron Lett. 1976, 4675

23 Heathcock CH. Pirrung MC. Montgomery SH. Lampe J. Tetrahedron 1981, 37: 4087

24 Neises B. Steglich W. Angew. Chem., Int. Ed. Engl. 1978, 17: 522